The PTEN-AKT-mTOR/RICTOR Pathway in Nasal Natural Killer Cell Lymphoma Is Activated by miR-494-3p via PTEN But Inhibited by miR-142-3p via RICTOR
- PMID: 25907832
- DOI: 10.1016/j.ajpath.2015.01.025
The PTEN-AKT-mTOR/RICTOR Pathway in Nasal Natural Killer Cell Lymphoma Is Activated by miR-494-3p via PTEN But Inhibited by miR-142-3p via RICTOR
Abstract
Nasal natural killer (NK) cell lymphoma (NNL) is an Epstein-Barr virus-associated lymphoma of cytotoxic NK cell origin. The Epstein-Barr virus-encoded miR-BART20-5p inhibits T-bet (TBX21), the master transcription factor of cytotoxic NK cells. To further explore the roles of miRNAs in NNLs, we measured the miRNA expression profiles of 36 NNLs. miR-21, miR-142-3p, miR-126, miR-451, and miR-494-3p were the top five miRNAs with the highest expression levels. By using pathway analysis, we identified associations between all of the five miRNAs with the PTEN-AKT-mTOR pathway, in which PTEN suppresses the oncogenic AKT, and mTOR mediates the oncogenic effects of AKT. YT and NK92 cells derived from NK cell lymphomas were used. miR-494-3p inhibited PTEN with secondary activation of AKT in NK92 cells, and miR-142-3p inhibited RICTOR, a key component of the mTOR complex, with secondary suppression of AKT in YT cells. Significantly, T-bet inhibited the PTEN-AKT-mTOR/RICTOR pathway through induction of PTEN and suppression of RICTOR. Therefore, a molecular circuit of T-bet, PTEN, AKT, and RICTOR is regulated by miR-BART20-5p, miR-494-3p, and miR-142-3p. This circuit is involved in the pathogenesis of NNL. Hence, antagomirs to miR-BART20-5p or miR-494-3p, miR-142-3p mimics, or AKT inhibitors may be useful in NNL therapy.
Copyright © 2015 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Epstein-Barr virus-encoded miR-BART20-5p inhibits T-bet translation with secondary suppression of p53 in invasive nasal NK/T-cell lymphoma.Am J Pathol. 2013 May;182(5):1865-75. doi: 10.1016/j.ajpath.2013.01.025. Am J Pathol. 2013. PMID: 23608226
-
EBV-encoded miR-BART20-5p and miR-BART8 inhibit the IFN-γ-STAT1 pathway associated with disease progression in nasal NK-cell lymphoma.Am J Pathol. 2014 Apr;184(4):1185-97. doi: 10.1016/j.ajpath.2013.12.024. Am J Pathol. 2014. PMID: 24655378
-
MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.Oncotarget. 2015 Jun 20;6(17):15035-49. doi: 10.18632/oncotarget.3729. Oncotarget. 2015. PMID: 25909227 Free PMC article.
-
Regulation of the MIR155 host gene in physiological and pathological processes.Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Gene. 2013. PMID: 23246696 Review.
-
Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.Leukemia. 2011 Jul;25(7):1064-79. doi: 10.1038/leu.2011.46. Epub 2011 Mar 25. Leukemia. 2011. PMID: 21436840 Review.
Cited by
-
Transcriptional and post-transcriptional regulation of NK cell development and function.Clin Immunol. 2017 Apr;177:60-69. doi: 10.1016/j.clim.2016.03.003. Epub 2016 Mar 3. Clin Immunol. 2017. PMID: 26948928 Free PMC article. Review.
-
MIR494 reduces renal cancer cell survival coinciding with increased lipid droplets and mitochondrial changes.BMC Cancer. 2016 Jan 21;16:33. doi: 10.1186/s12885-016-2053-3. BMC Cancer. 2016. PMID: 26794413 Free PMC article.
-
A review on EBV encoded and EBV-induced host microRNAs expression profile in different lymphoma types.Mol Biol Rep. 2021 Feb;48(2):1801-1817. doi: 10.1007/s11033-021-06152-z. Epub 2021 Feb 1. Mol Biol Rep. 2021. PMID: 33523370 Review.
-
PI3 kinase signaling pathway in hematopoietic cancers: A glance in miRNA's role.J Clin Lab Anal. 2021 Apr;35(4):e23725. doi: 10.1002/jcla.23725. Epub 2021 Mar 5. J Clin Lab Anal. 2021. PMID: 33675064 Free PMC article. Review.
-
MicroRNA-142-3p inhibits IFN-γ production via targeting of RICTOR in Aspergillus fumigatus activated CD4+ T cells.Ann Transl Med. 2019 Nov;7(22):649. doi: 10.21037/atm.2019.10.85. Ann Transl Med. 2019. PMID: 31930050 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous